<p><em>新的数字平台结合了 8 周的成功蓝图、Dr. Smith AI 健康教练、AI 代理驱动的社区支持和 AI 驱动的终身健康模式，帮助用户在动力之外保持一致性</em></p>
<p>南卡罗来纳州洛克希尔 --（商业资讯）--Vynleads（OTCQB: VYND）今天宣布正式推出 Done With Diabetes™应用程序，这是一个以移动为主的数字健康平台，旨在帮助患有 2 型糖尿病、前驱糖尿病和代谢健康目标的成年人通过清晰的每日结构、个性化指导和 AI 驱动的健康教练建立可持续的生活方式。</p>
<p><img src="https://imageproxy.pbkrs.com/https://mms.businesswire.com/media/20260211919103/en/2718397/4/vynleads-done-with-diabetes-app-launch-ai-coach-blood-sugar-metabolic-health_copy.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://mms.businesswire.com/media/20260211919103/en/2718397/4/vynleads-done-with-diabetes-app-launch-ai-coach-blood-sugar-metabolic-health_copy.jpg"/></p>
<p>对于数百万糖尿病患者来说，糖尿病的管理通常是在短暂的临床访问中进行的，但结果却受到在家、工作和日常生活中做出的数百个日常决策的影响。Done With Diabetes™旨在弥补这一差距，将生活方式医学原则转化为简单、可重复的日常体验。</p>
<p>“我们为糖尿病的现实设计了这个平台——它是逐日管理的，” Vynleads 的联合创始人兼首席执行官 Alex Mannine 表示。“Done With Diabetes™为人们提供了一个清晰的计划，他们可以遵循，个性化指导会随着他们建立动力而调整，还有一个由 AI 代理和同伴支持的社区，让每个人在预约之间都不会感到孤单。目标很简单：让进步变得可持续。”</p>
<p><strong>用户在 Done With Diabetes™应用中获得的内容</strong></p>
<p>Done With Diabetes™应用围绕 Vynleads 的专有生活方式蓝图™构建。这个 AI 驱动的个性化引擎将程序体验与每个用户的目标、习惯和限制对齐。结果是一个结构化的糖尿病生活方式例行程序，旨在每天使用，而不是偶尔使用。</p>
<ul>
<li><strong>生活方式蓝图™个性化：</strong> 根据用户的反馈和在 8 周程序中的行动，量身定制每日目标、习惯和重点领域，并持续调整，以防止习惯回退。</li>
<li><strong>8 周成功蓝图：</strong> 一个结构化的 56 天旅程，包含分阶段模块（基础、餐饮计划、生活方式、控制），旨在逐步建立技能和例行，而没有 “你落后了” 的压力。</li>
<li><strong>Dr. Smith AI 健康教练：</strong> 上下文感知的教练，了解用户在程序中的位置，并可以帮助进行餐饮替换、现实规划、激励和教育问答，确保在明确的健康框架内进行。</li>
<li><strong>糖尿病友好的餐饮规划：</strong> 一个策划的库，包含 43 个以上低热量食谱，提供完整的营养数据、购物清单和实用指导，以减少决策疲劳。</li>
<li><strong>进度跟踪：</strong> 易于使用的仪表板，跟踪生活方式指标，如能量、压力、睡眠、水分、运动和习惯完成情况，以便进度保持可见。</li>
<li><strong>为一致性设计的参与：</strong> 积分、连胜、每日旋转、排行榜和一个视觉上反映一致性的健康花园，专门构建以强化长期遵守。</li>
<li><strong>社区支持和责任感：</strong> 论坛、胜利分享、每周/月挑战、伙伴匹配和指导路径，以及 AI 代理响应用户帖子和问题，帮助保持社区活跃、支持和友好。</li>
</ul>
<p><strong>AI 教练和 AI 增强社区，旨在支持现实生活</strong></p>
<p>Dr. Smith 作为一个随时可用的健康教练，帮助用户在关键时刻将教育转化为行动，无论是规划餐饮、应对挫折，还是在动力下降时保持一致性。在应用的社区部分，一组 AI 代理可以回答问题、鼓励进展，并指引用户找到相关的课程、每日任务、食谱和与他们在程序中所处位置相符的挑战。这些代理也会相互回应，以提供有用的视角，并在明确的健康框架内保持对话的流动，同时提供透明度控制，以便用户可以调整他们的参与方式。</p>
<p><strong>AI 驱动的终身健康模式：超越前 8 周的支持</strong></p>
<p>在初始的 56 天成功蓝图之后，用户将过渡到 AI 驱动的终身健康模式，这是一个旨在维护、预防复发和长期一致性的持续支持体验。应用程序不再默认提供通用建议，而是根据每个用户在整个程序中的反馈和行动，包括入职输入、任务完成、签到和整体参与情况进行调整。</p>
<p>然后，它利用这些数据个性化接下来的内容，从每周的重点领域和毕业后的任务到推荐的任务、食谱和挑战。结果是一个无摩擦的延续，使指导保持相关和可操作，帮助减少短期程序后常见的 “现在怎么办？” 的掉落。</p>
<p><strong>一个可扩展的数字健康平台，采用订阅模式</strong></p>
<p>对于利益相关者而言，此次发布标志着 Vynleads 向技术驱动的健康平台演变的一个里程碑。Done With Diabetes™应用程序以订阅模式推出——包括 7 天的免费试用和每月 29 美元的订阅——旨在支持经常性收入，同时保持广泛的可及性。该平台的参与循环（教练、社区、游戏化和毕业后支持）旨在随着时间的推移提高留存率和终身价值。</p>
<p>Vynleads 的长期愿景是建立一个不断扩展的 “Done With (DWX)” 系列条件感知生活方式项目，利用相同的 Lifestyle Blueprint™ 引擎、人工智能辅导和社区框架来应对更多由生活方式驱动的健康挑战。与直接面向消费者的推广同时进行，Vynleads 计划扩大 Done With Diabetes™ 在企业合作伙伴中的可用性，包括自保雇主、健康计划和支付方、医疗系统和提供者团体，以及寻求可扩展代谢健康支持的药房福利管理者。</p>
<p><strong>重要通知</strong></p>
<p>Done With Diabetes™ 和 Done With Diabetes™ 应用程序仅用于一般健康和教育目的，并不旨在诊断、治疗、治愈或预防任何疾病。用户应咨询合格的医疗专业人员，关于任何医疗状况以及在更改药物、饮食或锻炼方案之前。</p>
<p><strong>关于 Vynleads</strong></p>
<p>Vynleads (OTCQB: VYND) 是一家专注于生活方式优先项目的健康公司，旨在帮助消费者应对慢性、由生活方式驱动的健康挑战。以 Done With Diabetes™ 为起点，公司的愿景是开发一系列 “Done With (DWX)” 产品，结合基于证据的内容、结构化的行为改变和技术支持。有关更多信息，请访问 www.vynleads.com。</p>
<p><strong>前瞻性声明</strong></p>
<p>本新闻稿包含 Vynleads 及其代表根据 1995 年《私人证券诉讼改革法》所作的前瞻性声明。这些声明可以通过诸如 “预计”、“计划”、“打算”、“相信”、“将”、“估计”、“预测”、“项目” 或类似含义的词语以及它们与历史或当前事实并不严格相关的事实来识别。前瞻性声明通常用于讨论潜在的产品应用、潜在的合作、产品开发活动、临床研究、监管提交和批准以及类似的运营事项。许多因素可能导致实际结果与前瞻性声明不同，包括不准确的假设和各种已知及未知的风险和不确定性。已知的风险和不确定性包括 Vynleads 不时向证券交易委员会提交的报告中识别的那些。没有任何前瞻性声明能保证未来的结果或事件，且应避免对这些声明过度依赖。Vynleads 不承担公开更新任何前瞻性声明的义务，无论是由于新信息、未来事件还是其他原因。</p>
<p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjAyMTE5MTkxMDNyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjAyMTE5MTkxMDNyMQ"/></p>
<p>在 businesswire.com 上查看源版本：https://www.businesswire.com/news/home/20260211919103/en/</p>
<p><strong>媒体联系</strong></p>
<p>Nick Mitsis</p>
<p>Percepture</p>
<p>nmitsis@percepture.com</p>
<p>来源：Vynleads</p>

美国制药 ETF - iShares

医药突破 ETF - ALPS

动态生物技术与基因组 ETF - Invesco

<p>Vynleads（OTCQB: VYND）推出了 Done With Diabetes™应用程序，这是一个旨在帮助成年人管理 2 型糖尿病和代谢健康的数字健康平台。该应用程序具有 8 周成功蓝图、人工智能健康指导、个性化生活方式方案和社区支持。它采用订阅模式，提供 7 天的免费试用，并旨在通过其人工智能驱动的终身健康模式提供持续支持。这次发布标志着 Vynleads 向技术驱动的健康平台演变的重要一步，并计划未来扩展到其他健康挑战</p>

<p><em>New digital platform combines an 8-week Success Blueprint, Dr. Smith AI Wellness Coach, AI Agent-powered community support, and AI-powered Lifetime Wellness Mode to help users stay consistent beyond motivation</em></p>
<div class="lb-trans"><p><em>新的数字平台结合了 8 周的成功蓝图、Dr. Smith AI 健康教练、AI 代理驱动的社区支持和 AI 驱动的终身健康模式，帮助用户在动力之外保持一致性</em></p>
</div><p>ROCK HILL, S.C.--(BUSINESS WIRE)--Vynleads (OTCQB: VYND) today announced the official launch of the Done With Diabetes™ app, a mobile-first digital wellness platform designed to help adults with type 2 diabetes, prediabetes, and metabolic health goals build sustainable lifestyle routines through clear daily structure, personalized guidance, and AI-powered wellness coaching.</p>
<div class="lb-trans"><p>南卡罗来纳州洛克希尔 --（商业资讯）--Vynleads（OTCQB: VYND）今天宣布正式推出 Done With Diabetes™应用程序，这是一个以移动为主的数字健康平台，旨在帮助患有 2 型糖尿病、前驱糖尿病和代谢健康目标的成年人通过清晰的每日结构、个性化指导和 AI 驱动的健康教练建立可持续的生活方式。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://mms.businesswire.com/media/20260211919103/en/2718397/4/vynleads-done-with-diabetes-app-launch-ai-coach-blood-sugar-metabolic-health_copy.jpg" alt="" original-src="https://mms.businesswire.com/media/20260211919103/en/2718397/4/vynleads-done-with-diabetes-app-launch-ai-coach-blood-sugar-metabolic-health_copy.jpg"/></p>
<p>For millions of people, diabetes is managed during brief clinical visits, yet outcomes are shaped by hundreds of daily decisions made at home, at work, and in everyday life. Done With Diabetes™ was built to close that gap by translating lifestyle medicine principles into a simple, repeatable day-by-day experience.</p>
<div class="lb-trans"><p>对于数百万糖尿病患者来说，糖尿病的管理通常是在短暂的临床访问中进行的，但结果却受到在家、工作和日常生活中做出的数百个日常决策的影响。Done With Diabetes™旨在弥补这一差距，将生活方式医学原则转化为简单、可重复的日常体验。</p>
</div><p>&#34;We designed this platform for the reality of diabetes—it’s managed day by day,” said Alex Mannine, Co-Founder and CEO of Vynleads. “Done With Diabetes™ gives people a clear plan they can follow, with personalized guidance that adapts as they build momentum, plus a Community supported by AI Agents and peers so no one feels alone between appointments. The goal is simple: make progress sustainable.”</p>
<div class="lb-trans"><p>“我们为糖尿病的现实设计了这个平台——它是逐日管理的，” Vynleads 的联合创始人兼首席执行官 Alex Mannine 表示。“Done With Diabetes™为人们提供了一个清晰的计划，他们可以遵循，个性化指导会随着他们建立动力而调整，还有一个由 AI 代理和同伴支持的社区，让每个人在预约之间都不会感到孤单。目标很简单：让进步变得可持续。”</p>
</div><p><strong>What Users Get Inside the Done With Diabetes™ App</strong></p>
<div class="lb-trans"><p><strong>用户在 Done With Diabetes™应用中获得的内容</strong></p>
</div><p>The Done With Diabetes™ app is built around Vynleads’ proprietary Lifestyle Blueprint™. This AI-powered personalization engine aligns the program experience to each user’s goals, habits, and constraints. The result is a structured diabetes lifestyle routine that is designed to be used daily, not occasionally.</p>
<div class="lb-trans"><p>Done With Diabetes™应用围绕 Vynleads 的专有生活方式蓝图™构建。这个 AI 驱动的个性化引擎将程序体验与每个用户的目标、习惯和限制对齐。结果是一个结构化的糖尿病生活方式例行程序，旨在每天使用，而不是偶尔使用。</p>
</div><ul>
<li><strong>Lifestyle Blueprint™ Personalization:</strong> Tailors daily targets, habits, and focus areas, and continues adapting based on the user’s responses and actions throughout the 8-week program and into Vynleads’ Lifetime Wellness Mode to prevent habit regression.</li>
<li><strong>8-week Success Blueprint:</strong> A structured 56-day journey with phased modules (Foundation, Meal Plan, Lifestyle, Control) designed to build skills and routines progressively without the “you’re behind” pressure.</li>
<li><strong>Dr. Smith AI Wellness Coach:</strong> Context-aware coaching that understands where a user is in the program and can help with meal swaps, real-world planning, motivation, and educational Q&amp;A within clear wellness guardrails.</li>
<li><strong>Diabetes-Friendly Meal Planning:</strong> A curated library of 43+ lower-calorie recipes with full nutrition data, shopping lists, and practical guidance to reduce decision fatigue.</li>
<li><strong>Progress Tracking</strong>: Easy-to-use dashboards for lifestyle metrics such as energy, stress, sleep, hydration, movement, and habit completion, so progress stays visible.</li>
<li><strong>Engagement Designed for Consistency:</strong> Points, streaks, a Daily Spin, leaderboards, and a Wellness Garden that visually reflects consistency and is specifically built to reinforce adherence over time.</li>
<li><strong>Community Support and Accountability:</strong> Forums, victory sharing, weekly/monthly challenges, buddy matching, and mentorship pathways, plus AI Agents that respond to user posts and questions to help keep the community active, supportive, and welcoming.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>生活方式蓝图™个性化：</strong> 根据用户的反馈和在 8 周程序中的行动，量身定制每日目标、习惯和重点领域，并持续调整，以防止习惯回退。</li>
<li><strong>8 周成功蓝图：</strong> 一个结构化的 56 天旅程，包含分阶段模块（基础、餐饮计划、生活方式、控制），旨在逐步建立技能和例行，而没有 “你落后了” 的压力。</li>
<li><strong>Dr. Smith AI 健康教练：</strong> 上下文感知的教练，了解用户在程序中的位置，并可以帮助进行餐饮替换、现实规划、激励和教育问答，确保在明确的健康框架内进行。</li>
<li><strong>糖尿病友好的餐饮规划：</strong> 一个策划的库，包含 43 个以上低热量食谱，提供完整的营养数据、购物清单和实用指导，以减少决策疲劳。</li>
<li><strong>进度跟踪：</strong> 易于使用的仪表板，跟踪生活方式指标，如能量、压力、睡眠、水分、运动和习惯完成情况，以便进度保持可见。</li>
<li><strong>为一致性设计的参与：</strong> 积分、连胜、每日旋转、排行榜和一个视觉上反映一致性的健康花园，专门构建以强化长期遵守。</li>
<li><strong>社区支持和责任感：</strong> 论坛、胜利分享、每周/月挑战、伙伴匹配和指导路径，以及 AI 代理响应用户帖子和问题，帮助保持社区活跃、支持和友好。</li>
</ul>
</div><p><strong>AI Coaching and AI-Enhanced Community, Designed to Support Real Life</strong></p>
<div class="lb-trans"><p><strong>AI 教练和 AI 增强社区，旨在支持现实生活</strong></p>
</div><p>Dr. Smith functions as an always-available wellness coach who helps users turn education into action in the moments that matter, whether planning meals, navigating setbacks, or maintaining consistency when motivation declines. In the app’s Community section, a set of AI Agents can respond to questions, encourage progress, and point users to relevant lessons, daily missions, recipes, and challenges aligned with where they are in the program. These Agents also respond to one another to surface helpful perspectives and keep conversations moving within clear wellness-only guardrails, and with transparency controls so users can tailor how they engage.</p>
<div class="lb-trans"><p>Dr. Smith 作为一个随时可用的健康教练，帮助用户在关键时刻将教育转化为行动，无论是规划餐饮、应对挫折，还是在动力下降时保持一致性。在应用的社区部分，一组 AI 代理可以回答问题、鼓励进展，并指引用户找到相关的课程、每日任务、食谱和与他们在程序中所处位置相符的挑战。这些代理也会相互回应，以提供有用的视角，并在明确的健康框架内保持对话的流动，同时提供透明度控制，以便用户可以调整他们的参与方式。</p>
</div><p><strong>AI-Powered Lifetime Wellness Mode: Support Beyond the First 8 Weeks</strong></p>
<div class="lb-trans"><p><strong>AI 驱动的终身健康模式：超越前 8 周的支持</strong></p>
</div><p>After the initial 56-day Success Blueprint, users transition into the AI-powered Lifetime Wellness Mode, an ongoing support experience designed for maintenance, relapse prevention, and long-term consistency. Instead of defaulting to generic recommendations, the app draws on each user’s responses and actions throughout the program, including onboarding inputs, mission completion, check-ins, and overall engagement.</p>
<div class="lb-trans"><p>在初始的 56 天成功蓝图之后，用户将过渡到 AI 驱动的终身健康模式，这是一个旨在维护、预防复发和长期一致性的持续支持体验。应用程序不再默认提供通用建议，而是根据每个用户在整个程序中的反馈和行动，包括入职输入、任务完成、签到和整体参与情况进行调整。</p>
</div><p>It then uses that data to personalize what comes next, from weekly focus areas and post-graduation tasks to recommended missions, recipes, and challenges. The result is a frictionless continuation that keeps guidance relevant and actionable, helping reduce the “what now?” drop-off that often follows short-term programs.</p>
<div class="lb-trans"><p>然后，它利用这些数据个性化接下来的内容，从每周的重点领域和毕业后的任务到推荐的任务、食谱和挑战。结果是一个无摩擦的延续，使指导保持相关和可操作，帮助减少短期程序后常见的 “现在怎么办？” 的掉落。</p>
</div><p><strong>A Scalable Digital Wellness Platform with a Subscription Model</strong></p>
<div class="lb-trans"><p><strong>一个可扩展的数字健康平台，采用订阅模式</strong></p>
</div><p>For stakeholders, the launch represents a milestone in Vynleads’ evolution into a technology-enabled wellness platform. The Done With Diabetes™ app is launching as a subscription model—including a 7-day free trial and a $29/month subscription—designed to support recurring revenue while maintaining broad accessibility. The platform’s engagement loops (coaching, community, gamification, and post-graduation support) are intended to improve retention and lifetime value over time.</p>
<div class="lb-trans"><p>对于利益相关者而言，此次发布标志着 Vynleads 向技术驱动的健康平台演变的一个里程碑。Done With Diabetes™应用程序以订阅模式推出——包括 7 天的免费试用和每月 29 美元的订阅——旨在支持经常性收入，同时保持广泛的可及性。该平台的参与循环（教练、社区、游戏化和毕业后支持）旨在随着时间的推移提高留存率和终身价值。</p>
</div><p>Vynleads’ long-term vision is to build an expanding “Done With (DWX)” family of condition-aware lifestyle programs on a single platform, leveraging the same Lifestyle Blueprint™ engine, AI coaching, and community framework to address additional lifestyle-driven health challenges. In parallel with the direct-to-consumer rollout, Vynleads plans to expand Done With Diabetes™ availability for enterprise partners that include self-insured employers, health plans and payers, healthcare systems and provider groups, and pharmacy benefit managers seeking scalable metabolic health support for the individuals they serve.</p>
<div class="lb-trans"><p>Vynleads 的长期愿景是建立一个不断扩展的 “Done With (DWX)” 系列条件感知生活方式项目，利用相同的 Lifestyle Blueprint™ 引擎、人工智能辅导和社区框架来应对更多由生活方式驱动的健康挑战。与直接面向消费者的推广同时进行，Vynleads 计划扩大 Done With Diabetes™ 在企业合作伙伴中的可用性，包括自保雇主、健康计划和支付方、医疗系统和提供者团体，以及寻求可扩展代谢健康支持的药房福利管理者。</p>
</div><p><strong>Important Notice</strong></p>
<div class="lb-trans"><p><strong>重要通知</strong></p>
</div><p>Done With Diabetes™ and the Done With Diabetes™ app are intended for general wellness and educational purposes only and are not intended to diagnose, treat, cure, or prevent any disease. Users should consult a qualified healthcare professional regarding any medical condition and before making changes to medications, diet, or exercise routines.</p>
<div class="lb-trans"><p>Done With Diabetes™ 和 Done With Diabetes™ 应用程序仅用于一般健康和教育目的，并不旨在诊断、治疗、治愈或预防任何疾病。用户应咨询合格的医疗专业人员，关于任何医疗状况以及在更改药物、饮食或锻炼方案之前。</p>
</div><p><strong>About Vynleads</strong></p>
<div class="lb-trans"><p><strong>关于 Vynleads</strong></p>
</div><p>Vynleads (OTCQB: VYND) is a wellness company focused on lifestyle-first programs designed to help consumers address chronic, lifestyle-driven health challenges. Beginning with Done With Diabetes™, the Company’s vision is to develop a portfolio of “Done With (DWX)” offerings that combine evidence-informed content, structured behavior change, and technology-enabled support. For more information, visit www.vynleads.com.</p>
<div class="lb-trans"><p>Vynleads (OTCQB: VYND) 是一家专注于生活方式优先项目的健康公司，旨在帮助消费者应对慢性、由生活方式驱动的健康挑战。以 Done With Diabetes™ 为起点，公司的愿景是开发一系列 “Done With (DWX)” 产品，结合基于证据的内容、结构化的行为改变和技术支持。有关更多信息，请访问 www.vynleads.com。</p>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This press release contains forward-looking statements made within the meaning of the Private Securities Litigation Reform Act of 1995 by Vynleads and its representatives. These statements can be identified by introductory words such as “expects,” “plans,” “intends,” “believes,” “will,” “estimates,” “forecasts,” “projects,” or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in reports filed by Vynleads with the Securities and Exchange Commission. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Vynleads undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.</p>
<div class="lb-trans"><p>本新闻稿包含 Vynleads 及其代表根据 1995 年《私人证券诉讼改革法》所作的前瞻性声明。这些声明可以通过诸如 “预计”、“计划”、“打算”、“相信”、“将”、“估计”、“预测”、“项目” 或类似含义的词语以及它们与历史或当前事实并不严格相关的事实来识别。前瞻性声明通常用于讨论潜在的产品应用、潜在的合作、产品开发活动、临床研究、监管提交和批准以及类似的运营事项。许多因素可能导致实际结果与前瞻性声明不同，包括不准确的假设和各种已知及未知的风险和不确定性。已知的风险和不确定性包括 Vynleads 不时向证券交易委员会提交的报告中识别的那些。没有任何前瞻性声明能保证未来的结果或事件，且应避免对这些声明过度依赖。Vynleads 不承担公开更新任何前瞻性声明的义务，无论是由于新信息、未来事件还是其他原因。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjAyMTE5MTkxMDNyMQ" alt="" original-src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260211919103r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en"/></p>
<p>View source version on businesswire.com: https://www.businesswire.com/news/home/20260211919103/en/</p>
<div class="lb-trans"><p>在 businesswire.com 上查看源版本：https://www.businesswire.com/news/home/20260211919103/en/</p>
</div><p><strong>Media Contact</strong></p>
<div class="lb-trans"><p><strong>媒体联系</strong></p>
</div><p>Nick Mitsis</p>
<div class="lb-trans"><p>Nick Mitsis</p>
</div><p>Percepture</p>
<div class="lb-trans"><p>Percepture</p>
</div><p>nmitsis@percepture.com</p>
<div class="lb-trans"><p>nmitsis@percepture.com</p>
</div><p>Source: Vynleads</p>
<div class="lb-trans"><p>来源：Vynleads</p>
</div>

Vynleads (OTCQB: VYND) Launches Done With Diabetes™ App, Bringing AI-Powered Daily Lifestyle Support to Blood Sugar and Metabolic Health | VYND Stock News

StockTitan

VYNE Therapeutics

医疗业 ETF - SPDR

纳斯达克生物科技指数 ETF - iShares Nasdaq

2 倍做多纳斯达克生物技术 ETF - ProShares

医疗业 ETF - Vanguard

标普全球医疗股指数 ETF - iShares

标普生物技术 ETF - SPDR

纽交所高增长板生物技术指数 ETF - First Trust

基因改革 ETF - ARK

生物科技 ETF - VanEck Vectors

Vynleads (OTCQB: VYND) 推出 Done With Diabetes™ 应用程序，提供人工智能支持的日常生活方式帮助，以改善血糖和代谢健康 | VYND 股票新闻